Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis.

Documenti analoghi

• Pharmacokinetics of meropenem (ICI 194,660) and its metabolite (ICI 213,689) in healthy subjects and in patients with renal impairment.
  di: Leroy, A, et al.
  Pubblicazione: (1992)
• The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function
  di: Aweeka, F, et al.
  Pubblicazione: (2000)
• Pharmacokinetics of metioprim in normal subjects and patients with impaired renal function.
  di: Vergin, H, et al.
  Pubblicazione: (1983)
• Single‐Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End‐Stage Renal Disease Requiring Hemodialysis
  di: Zomorodi, Katie, et al.
  Pubblicazione: (2019)
• Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.
  di: Leroy, A, et al.
  Pubblicazione: (1990)